BI Asset Management Fondsmaeglerselskab A S boosted its stake in Cigna Group (NYSE:CI – Free Report) by 99.2% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 35,118 shares of the health services provider’s stock after buying an additional 17,488 shares during the quarter. BI Asset Management Fondsmaeglerselskab A S’s holdings in Cigna Group were worth $9,368,000 at the end of the most recent quarter.
Other institutional investors also recently modified their holdings of the company. Vanguard Group Inc. increased its stake in shares of Cigna Group by 1.6% in the fourth quarter. Vanguard Group Inc. now owns 26,173,577 shares of the health services provider’s stock worth $7,203,754,000 after acquiring an additional 414,834 shares during the last quarter. State Street Corp raised its holdings in shares of Cigna Group by 1.8% during the fourth quarter. State Street Corp now owns 12,339,250 shares of the health services provider’s stock worth $3,396,132,000 after acquiring an additional 224,122 shares in the last quarter. Massachusetts Financial Services Co. MA boosted its position in Cigna Group by 8.3% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 11,805,083 shares of the health services provider’s stock valued at $3,249,113,000 after purchasing an additional 903,334 shares during the last quarter. Dodge & Cox boosted its position in Cigna Group by 19.7% during the fourth quarter. Dodge & Cox now owns 11,138,614 shares of the health services provider’s stock valued at $3,065,681,000 after purchasing an additional 1,833,389 shares during the last quarter. Finally, Sanders Capital LLC grew its stake in Cigna Group by 0.5% in the third quarter. Sanders Capital LLC now owns 7,828,168 shares of the health services provider’s stock valued at $2,256,469,000 after purchasing an additional 35,150 shares in the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.
Analysts Set New Price Targets
Several research analysts have weighed in on CI shares. Morgan Stanley upped their target price on Cigna Group from $355.00 to $361.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 20th. Guggenheim lifted their price target on Cigna Group from $334.00 to $338.00 and gave the company a “buy” rating in a report on Monday, May 4th. The Goldman Sachs Group boosted their price target on Cigna Group from $335.00 to $340.00 and gave the company a “buy” rating in a research note on Monday, May 4th. Raymond James Financial set a $340.00 price objective on Cigna Group in a report on Friday, May 1st. Finally, UBS Group raised their price objective on shares of Cigna Group from $375.00 to $400.00 and gave the company a “buy” rating in a research report on Friday, May 22nd. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat.com, Cigna Group presently has a consensus rating of “Moderate Buy” and a consensus target price of $338.30.
Cigna Group Stock Performance
CI opened at $279.63 on Monday. The company has a market cap of $73.97 billion, a PE ratio of 11.85, a price-to-earnings-growth ratio of 1.08 and a beta of 0.28. The stock has a 50-day moving average of $283.79 and a 200-day moving average of $278.36. Cigna Group has a 52-week low of $239.51 and a 52-week high of $338.89. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.73 and a current ratio of 0.73.
Cigna Group (NYSE:CI – Get Free Report) last posted its quarterly earnings data on Thursday, April 30th. The health services provider reported $7.79 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.60 by $0.19. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The business had revenue of $68.52 billion during the quarter, compared to the consensus estimate of $66.29 billion. During the same period in the prior year, the firm earned $6.74 EPS. Cigna Group’s quarterly revenue was up 4.6% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.350- EPS. As a group, equities research analysts forecast that Cigna Group will post 30.39 earnings per share for the current fiscal year.
Cigna Group Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Thursday, June 18th. Investors of record on Thursday, June 4th were paid a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a yield of 2.2%. The ex-dividend date was Thursday, June 4th. Cigna Group’s payout ratio is currently 26.45%.
Insider Activity at Cigna Group
In other news, CEO David Cordani sold 201,878 shares of the stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total value of $59,113,915.96. Following the completion of the transaction, the chief executive officer owned 34,337 shares in the company, valued at approximately $10,054,560.34. This represents a 85.46% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the firm’s stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $298.61, for a total transaction of $268,450.39. Following the transaction, the chief accounting officer directly owned 2,368 shares of the company’s stock, valued at $707,108.48. The trade was a 27.52% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 0.60% of the company’s stock.
Cigna Group Profile
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
See Also
- Five stocks we like better than Cigna Group
- 3 Inflation-Fighting Stocks Built for Higher Oil Prices
- 3 Biotech Firms With Major Potential Catalysts in the Coming Months
- Applied Materials Stock Looks Pricey—Can AI Demand Justify the Rally?
- 3 Small-Cap Stocks Getting a Russell 2000 Rebalance Boost
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
